BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177 | -46.7% | 25 | -50.0% | 0.00% | – |
| Q2 2023 | $332 | +104.9% | 50 | +92.3% | 0.00% | – |
| Q1 2023 | $162 | +362.9% | 26 | -99.5% | 0.00% | -100.0% |
| Q4 2022 | $35 | -99.9% | 5,543 | -3.6% | 0.00% | 0.0% |
| Q3 2022 | $36,000 | 0.0% | 5,751 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $36,000 | -2.7% | 5,751 | -1.3% | 0.00% | – |
| Q1 2022 | $37,000 | +3600.0% | 5,829 | +7373.1% | 0.00% | – |
| Q4 2021 | $1,000 | -85.7% | 78 | -85.5% | 0.00% | – |
| Q3 2021 | $7,000 | -95.0% | 538 | -93.9% | 0.00% | -100.0% |
| Q2 2021 | $140,000 | +122.2% | 8,822 | +44.6% | 0.00% | +200.0% |
| Q1 2021 | $63,000 | +14.5% | 6,099 | -16.4% | 0.00% | -50.0% |
| Q4 2020 | $55,000 | +685.7% | 7,295 | +231.6% | 0.00% | – |
| Q3 2020 | $7,000 | – | 2,200 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2017 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $8,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -70.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |